References
[1] He YB, Zhang GL, Guo JZ, et al. Complications and preventive measures of modified subtemporal transtentorial approach for resection of petroclival tumors [J]. Journal of Clinical Neurosurgery, 2020, 17(5): 549-553.
[2] Tao XG, Wei XT, Xue YK, et al. Resection of petroclival tumors through the anterior-subtemporal transanterior petrosal approach [J]. Chinese Journal of Minimally Invasive Neurosurgery, 2020, 25(12):529-532.
[3] Jiang C, Niu ZS, Ling SY. Clinical diagnosis and treatment of intraventricular central neurocytoma [J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2019, 29(3): 151-154.
[4] Jiang L, Sheng MF, Zhang Y, et al. The modified method of locating related bony structures in intradural anterior transpetrosal approach [J]. Chinese Journal of Experimental Surgery, 2019, 36(8): 1452-1454.
[5] Jiang C, Niu ZS, Ling SY, Jiang XF, Xia CY, Ding WH. Clinical diagnosis and treatment of intraventricular central neurocytoma [J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2016(3):151-154.
[6] Zhao P, Li B, Li CZ, Zhu HB, Gui SB, Zong XY, Wang XS, Zhang YZ. Complications and risk factors of neuroendoscopic treatment of intraventricular tumors [J]. Chinese Journal of Neurosurgery, 2018, 34(6):550-553.
[7] Tomio R, Horiguchi T, Borghei-Razavi H, Tamura R, Yoshida K, Kawase T. Anterior transpetrosal approach: experiences in 274 cases over 33 years. Technical variations, operated patients, and approach-related complications. J Neurosurg. 2021 Aug 13; 136(2):413-421. doi: 10.3171/2020.12.JNS204010. PMID: 34388716.
[8] Shin M, Hasegawa H, Miyawaki S, Kakigi A, Takizawa T, Kondo K, Shiode T, Kin T, Saito N. Endoscopic transmastoid posterior petrosal approach for locally aggressive tumors in the petrous part of the temporal bone involving the internal auditory canal, jugular foramen, and hypoglossal canal. J Neurosurg. 2019 Sep; 27:1-13. doi: 10.3171/2019.5.JNS19187. Epub ahead of print. PMID: 31561213.
[9] Li DM, Sun HW. Analysis of related factors of postoperative recurrence of WHO grade Ⅲ meningiomas [J]. The Journal of Practical Medicine, 2018, 34(24):4110-4114.
[10] Li GQ, Luo YH, Yu Y, et al. Recurrence Rate and Risk Factors of Atypical Meningioma:a Meta-analysis [J]. Acta Academiae Medicinae Sinicae, 2022, 44(4):570-578.
[11] Elbadry Ahmed R, Tang H, Asemota A, Huang L, Boling W, Bannout F. Meningioma Related Epilepsy- Pathophysiology, Pre/postoperative Seizures Predicators and Treatment. Front Oncol. 2022 Jul 4; 12:905976. doi: 10.3389/fonc.2022.905976. PMID: 35860576; PMCID: PMC9289540.
[12] Gyawali S, Sharma P, Mahapatra A. Meningioma and psychiatric symptoms: An individual patient data analysis. Asian J Psychiatr. 2019 Apr; 42:94-103. doi: 10.1016/j.ajp.2019.03.029. Epub 2019 Mar 28. PMID: 30999261.